Rochester Drug Cooperative Revenue and Competitors
Estimated Revenue & Valuation
- Rochester Drug Cooperative's estimated annual revenue is currently $28.1M per year.
- Rochester Drug Cooperative's estimated revenue per employee is $137,941
Employee Data
- Rochester Drug Cooperative has 204 Employees.
Rochester Drug Cooperative's People
| Name | Title | Email/Phone |
|---|
Rochester Drug Cooperative Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $13.1M | 65 | 7% | N/A | N/A |
#2 | $354.3M | 484 | -2% | $567.1M | N/A |
#3 | $347.1M | 1727 | -8% | N/A | N/A |
#4 | $8.8M | 44 | 13% | N/A | N/A |
#5 | $6M | 30 | 11% | N/A | N/A |
#6 | $46.6M | 232 | 4% | N/A | N/A |
#7 | $6.6M | 33 | -3% | N/A | N/A |
#8 | $11.3M | 56 | 12% | N/A | N/A |
#9 | $168.8M | 840 | 46% | N/A | N/A |
#10 | $12.3M | 61 | -21% | N/A | N/A |
What Is Rochester Drug Cooperative?
RDC is a true dividend-paying regional wholesale drug cooperative – a marriage of a traditional drug distribution company, a buying cooperative, and a private long-term investment structure formed for the sole benefit of pharmacist-entrepreneurs. We were founded in 1905 and currently rank as the 8th largest full-line distributor in the US.
keywords:N/A
N/A
Total Funding
204
Number of Employees
$28.1M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Rochester Drug Cooperative News
Rochester and Finger Lakes Counties Receive $9 Million in First Round of ... Bergen Drug Corporation, and Rochester Drug Cooperative Inc.
The cases against Mallinckrodt and Rochester Drug Cooperative are now moving separately through U.S. Bankruptcy Court, she said.
Cses against Mallinckrodt, Purdue Pharma, and Rochester Drug Cooperative are now moving separately through U.S. Bankruptcy Court.
Other Companies in Rochester
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $15M | 204 | 10% | N/A |
#2 | $22.6M | 205 | 7% | N/A |
#3 | $300M | 205 | -15% | N/A |
#4 | $62.4M | 210 | 46% | N/A |
#5 | $48.7M | 211 | 0% | N/A |